vs

Side-by-side financial comparison of RxSight, Inc. (RXST) and SolarMax Technology, Inc. (SMXT). Click either name above to swap in a different company.

SolarMax Technology, Inc. is the larger business by last-quarter revenue ($46.6M vs $32.6M, roughly 1.4× RxSight, Inc.). SolarMax Technology, Inc. runs the higher net margin — -1.9% vs -28.1%, a 26.2% gap on every dollar of revenue. On growth, SolarMax Technology, Inc. posted the faster year-over-year revenue change (623.5% vs -18.9%).

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

SolarMax Technology, Inc. develops, manufactures and sells high-efficiency solar PV modules and clean energy systems. It serves residential, commercial and industrial clients in North America and key Asia-Pacific markets, offering installation and after-sales support to boost low-carbon energy use.

RXST vs SMXT — Head-to-Head

Bigger by revenue
SMXT
SMXT
1.4× larger
SMXT
$46.6M
$32.6M
RXST
Growing faster (revenue YoY)
SMXT
SMXT
+642.4% gap
SMXT
623.5%
-18.9%
RXST
Higher net margin
SMXT
SMXT
26.2% more per $
SMXT
-1.9%
-28.1%
RXST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RXST
RXST
SMXT
SMXT
Revenue
$32.6M
$46.6M
Net Profit
$-9.2M
$-872.2K
Gross Margin
77.5%
2.7%
Operating Margin
-34.8%
-2.7%
Net Margin
-28.1%
-1.9%
Revenue YoY
-18.9%
623.5%
Net Profit YoY
-54.1%
77.7%
EPS (diluted)
$-0.22
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RXST
RXST
SMXT
SMXT
Q4 25
$32.6M
$46.6M
Q3 25
$30.3M
$30.6M
Q2 25
$33.6M
$6.9M
Q1 25
$37.9M
$6.9M
Q4 24
$40.2M
$6.4M
Q3 24
$35.3M
$6.3M
Q2 24
$34.9M
Q1 24
$29.5M
Net Profit
RXST
RXST
SMXT
SMXT
Q4 25
$-9.2M
$-872.2K
Q3 25
$-9.8M
$-2.3M
Q2 25
$-11.8M
$-1.9M
Q1 25
$-8.2M
$-1.3M
Q4 24
$-5.9M
$-3.9M
Q3 24
$-6.3M
$-9.6M
Q2 24
$-6.1M
Q1 24
$-9.1M
Gross Margin
RXST
RXST
SMXT
SMXT
Q4 25
77.5%
2.7%
Q3 25
79.9%
3.1%
Q2 25
74.9%
8.8%
Q1 25
74.8%
20.5%
Q4 24
71.6%
14.5%
Q3 24
71.4%
19.9%
Q2 24
69.5%
Q1 24
70.1%
Operating Margin
RXST
RXST
SMXT
SMXT
Q4 25
-34.8%
-2.7%
Q3 25
-40.1%
-6.9%
Q2 25
-41.6%
-25.7%
Q1 25
-28.2%
-16.7%
Q4 24
-21.5%
-27.9%
Q3 24
-26.1%
-158.4%
Q2 24
-23.9%
Q1 24
-36.2%
Net Margin
RXST
RXST
SMXT
SMXT
Q4 25
-28.1%
-1.9%
Q3 25
-32.4%
-7.4%
Q2 25
-35.0%
-27.6%
Q1 25
-21.6%
-18.7%
Q4 24
-14.8%
-60.6%
Q3 24
-17.9%
-152.0%
Q2 24
-17.4%
Q1 24
-30.8%
EPS (diluted)
RXST
RXST
SMXT
SMXT
Q4 25
$-0.22
$-0.02
Q3 25
$-0.24
$-0.04
Q2 25
$-0.29
$-0.04
Q1 25
$-0.20
$-0.03
Q4 24
$-0.14
$-0.07
Q3 24
$-0.16
$-0.21
Q2 24
$-0.16
Q1 24
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RXST
RXST
SMXT
SMXT
Cash + ST InvestmentsLiquidity on hand
$228.1M
$8.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.7M
$-12.2M
Total Assets
$311.8M
$91.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RXST
RXST
SMXT
SMXT
Q4 25
$228.1M
$8.0M
Q3 25
$227.5M
$5.7M
Q2 25
$227.5M
$1.9M
Q1 25
$229.3M
$6.8M
Q4 24
$237.2M
$7.1M
Q3 24
$237.1M
$8.6M
Q2 24
$233.3M
Q1 24
$125.4M
Stockholders' Equity
RXST
RXST
SMXT
SMXT
Q4 25
$275.7M
$-12.2M
Q3 25
$276.0M
$-11.8M
Q2 25
$278.0M
$-15.1M
Q1 25
$279.3M
$-15.9M
Q4 24
$281.2M
$-15.1M
Q3 24
$277.3M
$-10.9M
Q2 24
$275.2M
Q1 24
$163.9M
Total Assets
RXST
RXST
SMXT
SMXT
Q4 25
$311.8M
$91.3M
Q3 25
$308.5M
$58.7M
Q2 25
$309.0M
$38.2M
Q1 25
$313.0M
$38.6M
Q4 24
$318.6M
$38.6M
Q3 24
$310.5M
$43.0M
Q2 24
$305.5M
Q1 24
$183.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RXST
RXST
SMXT
SMXT
Operating Cash FlowLast quarter
$-1.1M
$-2.5M
Free Cash FlowOCF − Capex
$-2.3M
FCF MarginFCF / Revenue
-6.9%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RXST
RXST
SMXT
SMXT
Q4 25
$-1.1M
$-2.5M
Q3 25
$-1.2M
$3.4M
Q2 25
$-4.4M
$220.7K
Q1 25
$-8.8M
$-601.1K
Q4 24
$-4.3M
$-1.3M
Q3 24
$650.0K
$203.6K
Q2 24
$-4.0M
Q1 24
$-9.3M
Free Cash Flow
RXST
RXST
SMXT
SMXT
Q4 25
$-2.3M
Q3 25
$-1.8M
Q2 25
$-5.9M
Q1 25
$-9.4M
Q4 24
$-5.1M
Q3 24
$-453.0K
Q2 24
$-5.5M
Q1 24
$-11.3M
FCF Margin
RXST
RXST
SMXT
SMXT
Q4 25
-6.9%
Q3 25
-5.8%
Q2 25
-17.6%
Q1 25
-24.8%
Q4 24
-12.7%
Q3 24
-1.3%
Q2 24
-15.9%
Q1 24
-38.2%
Capex Intensity
RXST
RXST
SMXT
SMXT
Q4 25
3.5%
Q3 25
1.9%
Q2 25
4.6%
Q1 25
1.5%
Q4 24
2.1%
Q3 24
3.1%
0.0%
Q2 24
4.4%
Q1 24
6.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

SMXT
SMXT

Yabucoa$35.9M77%
Other$10.7M23%

Related Comparisons